Summary : FabiSpray will be marketed at a price of Rs 850 per unit. The recommended dosage for treatment of mild Covid-19…
Omnicron
-
-
CompaniesPfizer
Lawsuit over Pfizer’s disclosures before Chantix recall is dismissed
by adminby adminSummary : A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to…
-
Covid DrugsGlobal Market
Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
by adminby adminSummary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
-
Global MarketPharma Science & Research
Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs
by adminby adminSummary : Spain’s Rovi (ROVI.MC) has agreed a 10-year extension to its deal with Moderna (MRNA.O) to manufacture future drugs developed with…
-
Covid DrugsIndia
Emcure Pharma arm developing Covid vaccine targeting Omicron variant
by adminby adminSummary : India’s Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two,…
-
Covid DrugsIndia
Health ministry notifies provisions under Drugs Rules to manufacture, stock, sale new drugs in wake of Covid-19
by adminby adminSummary – The outbreak of Covid-19 pandemic has made it necessary to regulate the manufacture, stock, sale or distribution of new drug…
-
Covid DrugsIndia
Glenmark in partnership with SaNOtize launches FabiSpray in India for treatment of COVID-19
by adminby adminSynopsis : FabiSpray is a Nitric Oxide Nasal Spray (NONS) designed to kill the COVID-19 virus in the upper airways. It has…
-
CompaniesEli LillyRegulatoryU.S FDA
Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
by adminby adminSummary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates…
-
Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into…
-
Global Market
Pharma Nobis Completes Acquisition of Fagrons Contract Manufacturing Business and Manufacturing Facility
by adminby adminSynopsis : An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed…